JP2003516525A5 - - Google Patents

Download PDF

Info

Publication number
JP2003516525A5
JP2003516525A5 JP2001542908A JP2001542908A JP2003516525A5 JP 2003516525 A5 JP2003516525 A5 JP 2003516525A5 JP 2001542908 A JP2001542908 A JP 2001542908A JP 2001542908 A JP2001542908 A JP 2001542908A JP 2003516525 A5 JP2003516525 A5 JP 2003516525A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001542908A
Other languages
Japanese (ja)
Other versions
JP4612261B2 (ja
JP2003516525A (ja
Filing date
Publication date
Priority claimed from US09/459,137 external-priority patent/US6248353B1/en
Application filed filed Critical
Publication of JP2003516525A publication Critical patent/JP2003516525A/ja
Publication of JP2003516525A5 publication Critical patent/JP2003516525A5/ja
Application granted granted Critical
Publication of JP4612261B2 publication Critical patent/JP4612261B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001542908A 1999-12-10 2000-11-20 予め作製されたリポソームへの精製膜蛋白質の再構成 Expired - Fee Related JP4612261B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/459,137 US6248353B1 (en) 1999-12-10 1999-12-10 Reconstitution of purified membrane proteins into preformed liposomes
US09/459,137 1999-12-10
PCT/US2000/031927 WO2001041740A2 (en) 1999-12-10 2000-11-20 Reconstitution of purified membrane proteins into preformed liposomes

Publications (3)

Publication Number Publication Date
JP2003516525A JP2003516525A (ja) 2003-05-13
JP2003516525A5 true JP2003516525A5 (enExample) 2007-11-22
JP4612261B2 JP4612261B2 (ja) 2011-01-12

Family

ID=23823557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001542908A Expired - Fee Related JP4612261B2 (ja) 1999-12-10 2000-11-20 予め作製されたリポソームへの精製膜蛋白質の再構成

Country Status (7)

Country Link
US (2) US6248353B1 (enExample)
EP (1) EP1239833B1 (enExample)
JP (1) JP4612261B2 (enExample)
AT (1) ATE272393T1 (enExample)
DE (1) DE60012785T2 (enExample)
ES (1) ES2225271T3 (enExample)
WO (1) WO2001041740A2 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
DE69901377T2 (de) 1999-01-27 2003-01-02 Idea Ag Nichtinvasive Impfung durch die Haut
ATE216223T1 (de) 1999-01-27 2002-05-15 Idea Ag Transnasaler transport bzw. impfung mit hochadaptierbaren trägern
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US7622437B2 (en) * 2000-11-20 2009-11-24 The Board Of Trustees Of The University Of Illinois Tissue factor compositions and methods
EP1345959B1 (en) * 2000-11-20 2011-05-25 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US7592008B2 (en) * 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
US7083958B2 (en) * 2000-11-20 2006-08-01 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US6596543B2 (en) * 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
US7015193B2 (en) * 2001-04-20 2006-03-21 University Of Vermont Compositions and methods to control bleeding
CA2477982A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
US20050032113A1 (en) * 2003-07-17 2005-02-10 Mitsubishi Pharma Corporation Membrane protein library for proteome analysis and method for preparing same
WO2006083305A2 (en) 2004-06-23 2006-08-10 University Of Texas System Methods and compositions for the detection of biological molecules using a two particle complex
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
KR20070086045A (ko) * 2004-11-12 2007-08-27 이데아 아게 피부 상태 치료에서의 확대된 표면 집합체
CN101151533A (zh) * 2005-02-16 2008-03-26 伊利诺斯大学理事会 基于金属螯合脂质的促凝血剂
AT501650A1 (de) * 2005-02-22 2006-10-15 Technoclone Ges M B H Verfahren zur bestimmung der gerinnungsaktivierung sowie gerät zur durchführung des verfahrens
US7682808B2 (en) * 2005-03-04 2010-03-23 The Board Of Trustees Of The University Of Illinois Coagulation and fibrinolytic cascades modulator
US20080248565A1 (en) * 2007-03-01 2008-10-09 Invitrogen Corporation Isolated phospholipid-protein particles
US20070117179A1 (en) * 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
JP2007106679A (ja) * 2005-10-11 2007-04-26 Shino Test Corp 血液凝固反応促進剤
EP1939218A1 (en) * 2006-12-29 2008-07-02 Thrombotargets Europe, S.L. Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
CA2680206C (en) 2007-03-05 2015-07-07 Washington University Nanoparticle delivery systems for membrane-integrating peptides
JP5731198B2 (ja) 2007-09-27 2015-06-10 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
EP2062661A1 (en) * 2007-09-28 2009-05-27 Proviron Holding Organic de-icer removal
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
WO2009046194A2 (en) * 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
US20090220588A1 (en) * 2008-02-21 2009-09-03 Massachusetts Institute Of Technology Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity
AU2009253780B2 (en) 2008-06-05 2014-08-14 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
US8956600B2 (en) 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
US10894098B2 (en) 2012-04-09 2021-01-19 Signablok, Inc. Methods and compositions for targeted imaging
WO2011044545A2 (en) 2009-10-09 2011-04-14 Sigalov Alexander B Methods and compositions for targeted imaging
US12419839B2 (en) 2009-10-09 2025-09-23 Signablok, Inc. Methods and compositions for targeted delivery of protein fragments
KR101458315B1 (ko) 2013-07-19 2014-11-04 전북대학교산학협력단 표면 개질된 리포좀 및 그 제조방법
JP6652873B2 (ja) * 2016-03-30 2020-02-26 シスメックス株式会社 プロトロンビン時間測定用試薬、その製造方法およびプロトロンビン時間の測定方法
JP6626761B2 (ja) * 2016-03-30 2019-12-25 シスメックス株式会社 プロトロンビン時間測定用試薬およびその製造方法
US12246057B2 (en) 2018-04-13 2025-03-11 Board Of Regents, The University Of Texas System Transmembrane stem cell factor (tm-SCF) lipid nanocarriers and methods of use thereof
CN112368580B (zh) * 2018-07-06 2024-11-08 普和希株式会社 含有脂质体的液态凝血功能检测试剂
JP7153519B2 (ja) 2018-09-28 2022-10-14 シスメックス株式会社 凝固時間測定用試薬及びその製造方法、試薬キット及び凝固時間の測定方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL238873A (enExample) 1958-05-16
JPS56129859A (en) * 1980-03-14 1981-10-12 Sekisui Chem Co Ltd Plastic container for blood inspection
US4873089A (en) * 1985-07-12 1989-10-10 Cornell Research Foundation Inc., Cornell University Proteoliposomes as drug carriers
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
JPH0650999B2 (ja) 1988-09-12 1994-07-06 日本商事株式会社 血液凝固因子安定化法
US5472850A (en) 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
DE10075010I2 (de) 1990-06-28 2004-01-29 Hoechst Ag Fusionsproteine mit immunglobulinanteilen, ihre Herstellung und Verwendung.
US5314695A (en) 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
US5248590A (en) 1991-07-22 1993-09-28 Becton, Dickinson And Company Surface modified liposomes
WO1993007492A1 (en) * 1991-10-04 1993-04-15 Baxter Diagnostics Inc. Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids
AU674139B2 (en) 1992-04-13 1996-12-12 Ortho Diagnostic Systems Inc. Synthetic phospholipid reagent
US5358853A (en) 1992-08-03 1994-10-25 Akzo Av Liquid thromboplastin reagent
DE4243729A1 (de) 1992-12-23 1994-06-30 Behringwerke Ag Verfahren zur Reaktivierung von gereinigten Membranproteinen
JP3591837B2 (ja) 1994-02-17 2004-11-24 ニューヨーク・ブラッド・センター・インコーポレイテッド フィブリン膠およびリポソームを含有する生物学的生体接着剤組成物、その製造方法および使用
DE4416166C2 (de) 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
JP3246749B2 (ja) * 1997-04-23 2002-01-15 インストルメンテーション ラボラトリー エス．ピー．アー． 組換えウサギ組織因子に基づくプロトロンビン時間試薬
JP4039722B2 (ja) * 1997-12-01 2008-01-30 シスメックス株式会社 複合因子測定試薬
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes

Similar Documents

Publication Publication Date Title
BE2017C009I2 (enExample)
BE2014C035I2 (enExample)
BE2014C019I2 (enExample)
BE2013C060I2 (enExample)
BE2012C026I2 (enExample)
BE2012C016I2 (enExample)
BE2010C009I2 (enExample)
BE2010C018I2 (enExample)
BRPI0113420B8 (enExample)
BRPI0113085B8 (enExample)
AR028236A3 (enExample)
CN300955183S (zh) 连接件
BR122012015772A2 (enExample)
CL2006000179A1 (enExample)
CN3135789S (enExample)
AU2001273056A2 (enExample)
AU2000280296A8 (enExample)
AU2000278563A8 (enExample)
AU2000276780A8 (enExample)
AU2000266391A8 (enExample)
AU2000264849A8 (enExample)
BY6855C1 (enExample)
CN3141400S (enExample)
AU2000256911A8 (enExample)
CN3133795S (enExample)